What is Intest's earnings per share (EPS)?

Intest (INTT) reported diluted earnings per share of -$0.21 for fiscal year 2025. This represents a -187.5% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Intest (INTT) Financials

INTT

Trailing 12 months to March 31, 2026

Revenue $121.1M -5.0% YoY

Net Income $591K +691.0% YoY

EPS (Diluted) $0.04 +500.0% YoY

Free Cash Flow -$3.6M -159.0% YoY

Market Cap $139.2M as of Sep 3, 2026

Price / Sales 1.1x on $121.1M revenue, trailing 12 months to March 31, 2026

Price / Earnings 235x on $591K net income, trailing 12 months to March 31, 2026

Price / Book 1.3x on $104.5M equity, Q1 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 3, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported May 11, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q1 FY2026, filed May 11, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the INTT SEC filings page.

Intest (INTT) reported $121.1M in revenue over the twelve months to Mar 31, 2026, down 5.0% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI INTT FY2025 2026-08-29

InTest’s dominant mechanic is a shrinking revenue base exposing operating-cost rigidity while cash flow remains positive through noncash charges.

FY2025 paired a $2.5M net loss with $7.3M operating cash flow, a divergence that makes cash generation look healthier than the earnings engine. The cash conversion gap is partly explained by $6.8M of depreciation and amortization, while free cash flow remained $5.7M after capital spending.

Revenue fell to $113.8M in FY2025 even as gross margin recovered to 43.0%, so the pressure was not primarily at the direct-cost line. Operating margin moved from 2.6% in FY2024 to -3.3%, indicating that the cost base was not flexing enough with softer volume.

Liabilities of $47.7M against $151.3M of assets indicate low balance-sheet leverage, making the recent deterioration more an operating issue than a debt burden. ROA fell from 6.9% in FY2023 to -1.7% in FY2025, showing the asset base is currently producing less return.

Financial Health Signals

Financial Health Score 51/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Intest's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Intest has an operating margin of -3.3%, meaning the company loses $3 on every $100 of revenue. This results in a profitability score of 37/100. This is down from 2.6% the prior year.

Growth

Intest's revenue declined 12.9% year-over-year, from $130.7M to $113.8M. This contraction results in a growth score of 19/100.

Leverage

Intest carries a low D/E ratio of 0.01, meaning only $0.01 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 99/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Intest's current ratio of 2.20 indicates adequate short-term liquidity, earning a score of 64/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

Intest has a free cash flow margin of 5.0%, earning a moderate score of 48/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Intest posts a -2.4% return on equity (ROE), meaning it loses $2 for every $100 of shareholders' equity. This results in a returns score of 36/100. This is down from 2.9% the prior year.

Altman Z-Score Safe

3.16

Intest scores 3.16, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($139.2M) relative to total liabilities ($47.7M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral

4/9

Intest passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Mixed

N/A

Intest reported a net loss of $2.5M while generating $7.3M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

Intest reported an operating loss of $3.7M against $450K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$33.9M

YoY+27.2%

QoQ+3.2%

5Y CAGR+11.6%

10Y CAGR+14.6%

Intest generated $33.9M in revenue in Q1 2026. This represents an increase of 27.2% from the same quarter a year earlier. Against the prior quarter it is up 3.2%.

EBITDA

$2.6M

YoY+327.6%

QoQ-35.3%

Intest's EBITDA was $2.6M in Q1 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 327.6% from the same quarter a year earlier. Against the prior quarter it is down 35.3%.

Net Income

$789K

YoY+133.9%

QoQ-36.5%

5Y CAGR-18.6%

10Y CAGR+25.6%

Intest reported $789K in net income in Q1 2026. This represents an increase of 133.9% from the same quarter a year earlier. Against the prior quarter it is down 36.5%.

EPS (Diluted)

$0.06

YoY+131.6%

QoQ-40.0%

5Y CAGR-22.2%

10Y CAGR+19.6%

Intest earned $0.06 per diluted share (EPS) in Q1 2026. This represents an increase of 131.6% from the same quarter a year earlier. Against the prior quarter it is down 40.0%.

Cash & Balance Sheet

Free Cash Flow

-$4.0M

YoY-174.6%

QoQ-154.4%

Intest recorded an outflow of $4.0M in free cash flow in Q1 2026, representing a cash shortfall after capex. This represents a decrease of 174.6% from the same quarter a year earlier. Against the prior quarter it is down 154.4%.

Cash & Debt

$12.9M

YoY-41.6%

QoQ-9.5%

5Y CAGR+4.8%

10Y CAGR-6.4%

Intest held $12.9M in cash against $1.1M in long-term debt as of Q1 2026, with $35.8M of liabilities due within a year.

Shares Outstanding

13M

YoY+0.6%

QoQ+0.6%

5Y CAGR+3.2%

10Y CAGR+1.9%

Intest had 13M shares outstanding in Q1 2026. This represents an increase of 0.6% from the same quarter a year earlier. Against the prior quarter it is up 0.6%.

Dividends Per Share

Not reported for Q1 2026.

Margins & Returns

Gross Margin

45.5%

YoY+4.0pp

QoQ+0.1pp

5Y CAGR-3.2pp

10Y CAGR-1.6pp

Intest's gross margin was 45.5% in Q1 2026, indicating the percentage of revenue retained after direct costs. This is up 4.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.1 percentage points.

Operating Margin

2.8%

YoY+13.6pp

QoQ-1.1pp

Intest's operating margin was 2.8% in Q1 2026, reflecting core business profitability. This is up 13.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.1 percentage points.

Net Margin

2.3%

YoY+11.1pp

QoQ-1.5pp

5Y CAGR-9.0pp

10Y CAGR+1.4pp

Intest's net profit margin was 2.3% in Q1 2026, showing the share of revenue converted to profit. This is up 11.1 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.5 percentage points.

Return on Equity

0.8%

YoY+3.1pp

QoQ-0.4pp

5Y CAGR-3.9pp

10Y CAGR+0.5pp

Intest's ROE was 0.8% in Q1 2026, measuring profit generated per dollar of shareholder equity. This is up 3.1 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.4 percentage points.

Capital Allocation

R&D Spending

$2.6M

YoY+5.7%

QoQ+7.3%

Intest invested $2.6M in research and development in Q1 2026. This represents an increase of 5.7% from the same quarter a year earlier. Against the prior quarter it is up 7.3%.

Capital Expenditures

$644K

YoY+181.2%

QoQ+20.6%

5Y CAGR+10.7%

10Y CAGR+32.7%

Intest invested $644K in capex in Q1 2026, funding long-term assets and infrastructure. This represents an increase of 181.2% from the same quarter a year earlier. Against the prior quarter it is up 20.6%.

Share Buybacks

Not reported for Q1 2026.

INTT Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

INTT quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$121.1M	$113.8M-12.9%	$130.7M+6.0%	$123.3M+5.5%	$116.8M+37.6%	$84.9M+57.7%	$53.8M-11.3%	$60.7M-22.8%	$78.6M+17.6%	$66.8M+66.1%	$40.2M+3.4%	$38.9M-7.0%	$41.8M+6.0%	$39.4M-9.1%	$43.4M-8.2%	$47.3M
Cost of Revenue	$67.8M	$64.9M-13.8%	$75.3M+13.5%	$66.3M+4.6%	$63.4M+45.2%	$43.7M+46.9%	$29.7M-5.5%	$31.4M-19.7%	$39.2M+22.0%	$32.1M+61.8%	$19.8M-1.7%	$20.2M-5.4%	$21.3M+4.5%	$20.4M-16.1%	$24.3M-0.2%	$24.4M
Gross Profit	$53.3M	$48.9M-11.7%	$55.4M-2.7%	$57.0M+6.6%	$53.4M+29.6%	$41.2M+71.0%	$24.1M-17.5%	$29.2M-25.8%	$39.4M+13.6%	$34.7M+70.2%	$20.4M+9.0%	$18.7M-8.6%	$20.5M+7.6%	$19.0M-0.2%	$19.1M-16.7%	$22.9M
R&D Expenses	$9.6M	$9.4M+10.4%	$8.5M+12.2%	$7.6M+1.2%	$7.5M+36.1%	$5.5M+9.1%	$5.1M+2.1%	$5.0M+1.1%	$4.9M+14.1%	$4.3M+17.5%	$3.7M-7.0%	$3.9M+9.9%	$3.6M-2.8%	$3.7M-5.4%	$3.9M+20.2%	$3.2M
SG&A Expenses	$22.5M	$22.2M-5.7%	$23.6M+10.5%	$21.3M+10.5%	$19.3M+21.6%	$15.9M+38.6%	$11.4M-12.1%	$13.0M+1.6%	$12.8M+9.5%	$11.7M+66.9%	$7.0M+9.4%	$6.4M+2.8%	$6.2M+4.3%	$6.0M-7.1%	$6.4M+1.0%	$6.4M
Operating Income	$110K	-$3.7M-209.8%	$3.4M-67.5%	$10.4M-2.6%	$10.7M+26.7%	$8.5M+795.1%	-$1.2M-147.7%	$2.5M-50.8%	$5.2M+43.5%	$3.6M-12.9%	$4.1M+61.8%	$2.6M-47.9%	$4.9M+24.1%	$4.0M+32.2%	$3.0M-60.5%	$7.6M
EBITDA	N/A	$3.1M-65.0%	$8.8M-41.9%	$15.1M-2.2%	$15.5M+33.2%	$11.6M+492.9%	$2.0M-65.9%	$5.7M-18.6%	$7.1M+30.8%	$5.4M+13.6%	$4.7M+43.1%	$3.3M-42.8%	$5.8M+20.5%	$4.8M+22.4%	$3.9M-50.7%	$8.0M
Interest Expense	$330K	$450K-46.8%	$846K+24.6%	$679K+6.9%	$635K+613.5%	$89K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$4K
Income Tax	-$47K	-$695K-223.4%	$563K-67.0%	$1.7M+1.3%	$1.7M+50.5%	$1.1M+433.0%	-$336K-219.1%	$282K-85.9%	$2.0M-29.9%	$2.9M+84.8%	$1.5M+114.5%	$722K-50.9%	$1.5M+57.9%	$931K+3.8%	$897K+140.7%	-$2.2M
Net Income	$591K	-$2.5M-187.4%	$2.9M-69.1%	$9.3M+10.4%	$8.5M+16.2%	$7.3M+913.7%	-$895K-138.5%	$2.3M-23.5%	$3.0M+211.5%	$975K-63.3%	$2.7M+42.8%	$1.9M-45.9%	$3.4M+11.8%	$3.1M+42.7%	$2.2M-78.1%	$9.9M
EPS (Basic)	N/A	-$0.21-187.5%	$0.24-70.7%	$0.82+3.8%	$0.79+12.9%	$0.70+877.8%	-$0.09-140.9%	$0.22-24.1%	$0.29+222.2%	$0.09-65.4%	$0.26+44.4%	$0.18-45.5%	$0.33+10.0%	$0.30+42.9%	$0.21-78.4%	$0.97
EPS (Diluted)	$0.04	-$0.21-187.5%	$0.24-69.6%	$0.79+1.3%	$0.78+14.7%	$0.68+855.6%	-$0.09-140.9%	$0.22-24.1%	$0.29+222.2%	$0.09-65.4%	$0.26+44.4%	$0.18-45.5%	$0.33+10.0%	$0.30+42.9%	$0.21-78.1%	$0.96
Diluted Shares (Avg)	N/A	12M-0.3%	12M+3.9%	12M+8.4%	11M+1.2%	11M+4.6%	10M-1.3%	10M+0.1%	10M+0.4%	10M+0.1%	10M-1.5%	10M+0.3%	10M+0.5%	10M+0.7%	10M+0.6%	10M

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Revenue	$33.9M+27.2%	$32.8M-10.3%	$26.2M-13.3%	$28.1M-17.2%	$26.6M-10.7%	$36.6M+31.3%	$30.3M-2.2%	$34.0M+4.4%
Cost of Revenue	$18.5M+18.6%	$17.9M	$15.2M-6.2%	$16.2M-20.0%	$15.6M-7.0%	N/A	$16.3M-1.4%	$20.2M+15.2%
Gross Profit	$15.4M+39.4%	$14.9M+2.5%	$11.0M-21.6%	$12.0M-13.2%	$11.1M-15.4%	$14.5M+16.8%	$14.0M-3.0%	$13.8M-8.2%
R&D Expenses	$2.6M+5.7%	$2.4M	$2.3M+7.0%	$2.2M+1.2%	$2.4M+23.5%	N/A	$2.2M+21.1%	$2.2M+11.9%
SG&A Expenses	$6.1M+5.3%	$5.5M	$5.1M-16.2%	$5.8M-7.7%	$5.8M+7.4%	N/A	$6.1M+4.0%	$6.2M+23.8%
Operating Income	$954K+133.1%	$1.3M	-$1.2M-345.0%	-$927K-375.9%	-$2.9M-685.6%	N/A	$487K-80.3%	$336K-90.0%
EBITDA	$2.6M+327.6%	$4.0M	-$35K-102.4%	$237K-80.8%	-$1.1M-164.3%	N/A	$1.4M-52.0%	$1.2M-68.1%
Interest Expense	$80K-60.0%	$36K	$95K-56.6%	$119K-53.0%	$200K+42.9%	N/A	$219K+30.4%	$253K+43.8%
Income Tax	$188K+140.9%	$134K-55.0%	-$289K-490.5%	-$80K-221.2%	-$460K-468.0%	$298K+168.5%	$74K-83.4%	$66K-88.5%
Net Income	$789K+133.9%	$1.2M-17.4%	-$938K-289.5%	-$503K-318.7%	-$2.3M-451.8%	$1.5M+3.4%	$495K-78.3%	$230K-91.8%
EPS (Basic)	$0.06+131.6%	$0.10-16.7%	-$0.08-300.0%	-$0.04-300.0%	-$0.19-416.7%	$0.120.0%	$0.04-78.9%	$0.02-92.0%
EPS (Diluted)	$0.06+131.6%	$0.10-16.7%	-$0.08-300.0%	-$0.04-300.0%	-$0.19-480.0%	$0.120.0%	$0.04-78.9%	$0.02-91.7%
Diluted Shares (Avg)	12M+2.0%	N/A	12M-0.4%	12M-0.9%	12M+0.2%	12M+0.8%	12M+0.3%	12M+5.4%

INTT Balance Sheet

INTT quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$151.3M-0.6%	$152.3M+12.9%	$134.8M+22.5%	$110.1M+5.9%	$103.9M+67.5%	$62.0M+3.9%	$59.7M-11.1%	$67.2M+7.5%	$62.5M+45.9%	$42.8M+7.2%	$40.0M+3.2%	$38.7M+9.2%	$35.5M+9.5%	$32.4M+3.7%	$31.2M
Current Assets	$78.6M-0.2%	$78.8M-8.1%	$85.8M+42.8%	$60.1M+15.3%	$52.1M+93.1%	$27.0M+8.3%	$24.9M-30.1%	$35.6M+14.9%	$31.0M-18.4%	$38.0M+10.9%	$34.3M+4.0%	$32.9M+13.2%	$29.1M+13.7%	$25.6M+3.2%	$24.8M
Cash & Equivalents	$14.2M-28.3%	$19.8M-56.2%	$45.3M+236.9%	$13.4M-36.6%	$21.2M+106.2%	$10.3M+35.0%	$7.6M-57.4%	$17.9M+34.4%	$13.3M-53.5%	$28.6M+11.3%	$25.7M+11.2%	$23.1M+21.6%	$19.0M+22.1%	$15.6M+11.6%	$14.0M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$31.6M+17.7%	$26.8M+33.6%	$20.1M-11.0%	$22.6M+75.4%	$12.9M+72.1%	$7.5M+4.1%	$7.2M+10.2%	$6.5M+31.3%	$5.0M+35.1%	$3.7M+4.4%	$3.5M-6.6%	$3.8M+16.2%	$3.2M+3.4%	$3.1M-19.5%	$3.9M
Accounts Receivable	$25.9M-12.2%	$29.5M+62.3%	$18.2M-14.3%	$21.2M+28.3%	$16.5M+96.0%	$8.4M-9.3%	$9.3M-12.0%	$10.6M-13.2%	$12.2M+126.3%	$5.4M+22.3%	$4.4M-12.7%	$5.0M-12.4%	$5.7M+4.5%	$5.5M-11.1%	$6.2M
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$32.4M+5.3%	$30.7M+41.5%	$21.7M+0.6%	$21.6M+0.7%	$21.4M+56.1%	$13.7M0.0%	$13.7M0.0%	$13.7M0.0%	$13.7M+705.3%	$1.7M0.0%	$1.7M0.0%	$1.7M0.0%	$1.7M0.0%	$1.7M+3.0%	$1.7M
Total Liabilities	$47.7M-9.2%	$52.5M+36.2%	$38.5M-14.5%	$45.1M-8.1%	$49.1M+184.1%	$17.3M+16.1%	$14.9M-38.8%	$24.3M+4.7%	$23.2M+359.0%	$5.1M+24.6%	$4.1M-7.1%	$4.4M+0.9%	$4.3M-5.4%	$4.6M-9.1%	$5.0M
Current Liabilities	$35.8M+11.9%	$31.9M+31.5%	$24.3M-9.6%	$26.9M+7.2%	$25.1M+183.1%	$8.9M+5.9%	$8.4M-61.0%	$21.4M+48.5%	$14.4M+185.2%	$5.1M+24.6%	$4.1M-7.1%	$4.4M+0.9%	$4.3M-5.4%	$4.6M-9.1%	$5.0M
Non-Current Liabilities	$11.9M-41.9%	$20.6M+44.2%	$14.2M-21.9%	$18.2M-24.0%	$24.0M+185.1%	$8.4M+29.2%	$6.5M+125.7%	$2.9M-67.1%	$8.8M	$0	$0	$0	$0	$0	$0
Long-Term Debt	$1.4M-81.3%	$7.5M-5.1%	$7.9M-34.0%	$12.0M-24.7%	$16.0M	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$103.6M+3.8%	$99.8M+3.6%	$96.3M+48.2%	$65.0M+18.5%	$54.8M+22.5%	$44.8M-0.2%	$44.8M+4.6%	$42.9M+9.1%	$39.3M+4.0%	$37.8M+5.2%	$35.9M+4.5%	$34.4M+10.3%	$31.1M+12.0%	$27.8M+6.2%	$26.2M
Retained Earnings	$42.6M-5.6%	$45.1M+6.9%	$42.2M+28.4%	$32.9M+34.7%	$24.4M+42.6%	$17.1M-5.0%	$18.0M+14.8%	$15.7M+24.0%	$12.6M+8.4%	$11.7M+29.5%	$9.0M+26.0%	$7.2M+92.6%	$3.7M+483.8%	$636K+192.7%	-$686K

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Total Assets	$150.8M+1.9%	$151.3M-0.6%	$148.3M-6.4%	$149.7M-6.8%	$148.0M-7.2%	$152.3M+12.9%	$158.4M+16.9%	$160.6M+20.8%
Current Assets	$79.6M+6.3%	$78.6M-0.2%	$75.1M-7.5%	$74.8M-8.0%	$74.9M-12.3%	$78.8M-8.1%	$81.2M-6.2%	$81.4M-2.6%
Cash & Equivalents	$12.9M-41.6%	$14.2M-28.3%	$16.2M-9.7%	$19.2M-5.5%	$22.0M-19.3%	$19.8M-56.2%	$18.0M-56.9%	$20.4M-45.6%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$30.5M+10.3%	$31.6M+17.7%	$28.0M-11.6%	$27.6M-3.3%	$27.6M-11.9%	$26.8M+33.6%	$31.7M+42.9%	$28.6M+23.8%
Accounts Receivable	$30.2M+42.4%	$25.9M-12.2%	$20.9M-26.3%	$23.3M-22.3%	$21.2M-7.4%	$29.5M+62.3%	$28.4M+36.9%	$30.1M+39.3%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$32.1M+2.9%	$32.4M+5.3%	$32.3M-0.5%	$32.4M-7.0%	$31.2M-6.1%	$30.7M+41.5%	$32.5M+50.5%	$34.9M+60.6%
Total Liabilities	$46.3M-4.8%	$47.7M-9.2%	$46.4M-20.0%	$47.1M-22.9%	$48.6M-19.2%	$52.5M+36.2%	$58.0M+39.8%	$61.1M+49.7%
Current Liabilities	$35.8M+14.4%	$35.8M+11.9%	$32.4M-9.7%	$31.0M-14.6%	$31.3M-21.0%	$31.9M+31.5%	$35.9M+35.1%	$36.3M+42.9%
Non-Current Liabilities	$10.5M-39.5%	$11.9M-41.9%	$14.0M-36.7%	$16.1M-35.1%	$17.3M-15.8%	$20.6M+44.2%	$22.1M+48.0%	$24.8M+60.8%
Long-Term Debt	$1.1M-77.4%	$1.4M-81.3%	$2.3M-70.1%	$3.7M-59.7%	$5.0M-54.2%	$7.5M-5.1%	$7.8M-12.8%	$9.1M-8.8%
Total Equity	$104.5M+5.1%	$103.6M+3.8%	$101.9M+1.5%	$102.6M+3.1%	$99.4M+0.1%	$99.8M+3.6%	$100.4M+6.9%	$99.5M+8.1%
Retained Earnings	$43.3M+1.4%	$42.6M-5.6%	$41.3M-5.2%	$42.3M-1.9%	$42.8M-0.2%	$45.1M+6.9%	$43.6M+7.0%	$43.1M+12.0%

INTT Cash Flow Statement

INTT quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	-$1.5M	$7.3M+91.4%	$3.8M-76.4%	$16.2M+1266.5%	-$1.4M-112.8%	$10.8M+233.8%	$3.2M+138.6%	-$8.4M-176.7%	$11.0M+51.3%	$7.2M+68.9%	$4.3M+22.6%	$3.5M-31.8%	$5.1M+36.0%	$3.8M-43.3%	$6.6M-15.0%	$7.8M
Depreciation & Amortization	N/A	$6.8M+26.0%	$5.4M+15.1%	$4.7M-1.1%	$4.7M+50.5%	$3.1M-0.9%	$3.2M-0.6%	$3.2M+70.7%	$1.9M+5.2%	$1.8M+197.0%	$599K-20.6%	$754K-14.2%	$879K+3.8%	$847K-9.2%	$933K+136.8%	$394K
Stock-Based Compensation	N/A	$1.6M-13.3%	$1.9M-9.3%	$2.0M+14.5%	$1.8M+23.2%	$1.4M+116.1%	$671K-24.1%	$884K+35.4%	$653K+89.8%	$344K+27.9%	$269K+126.1%	$119K	N/A	$128K+13.3%	$113K	N/A
Capital Expenditures	$2.0M	$1.6M+23.3%	$1.3M+2.6%	$1.3M-5.4%	$1.4M+37.3%	$994K+51.1%	$658K+6.1%	$620K-72.0%	$2.2M+196.9%	$745K+119.8%	$339K-43.4%	$599K-27.9%	$831K+96.0%	$424K-1.6%	$431K-44.7%	$780K
Free Cash Flow	-$3.6M	$5.7M+127.6%	$2.5M-83.3%	$14.9M+641.5%	-$2.8M-128.0%	$9.8M+280.2%	$2.6M+128.7%	-$9.0M-203.2%	$8.7M+34.6%	$6.5M+64.5%	$3.9M+36.2%	$2.9M-32.6%	$4.3M+28.5%	$3.3M-46.2%	$6.2M-11.8%	$7.0M
Investing Cash Flow	-$2.0M	-$1.6M+91.9%	-$20.1M-1453.1%	-$1.3M-10.1%	-$1.2M+94.5%	-$21.4M-3198.1%	-$648K-4.5%	-$620K+90.2%	-$6.3M+72.1%	-$22.7M-6587.6%	-$339K	N/A	N/A	N/A	-$4.2M-480.4%	-$726K
Financing Cash Flow	-$3.2M	-$8.2M+4.8%	-$8.6M-155.4%	$15.6M+518.1%	-$3.7M-117.2%	$21.7M+29458.1%	-$74K+93.5%	-$1.1M	N/A	-$62K+93.7%	-$978K	N/A	N/A	N/A	-$834K-2880.0%	$30K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$834K	N/A
Share Buybacks	N/A	$0-100.0%	$1.0M	$0	N/A	$0-100.0%	$74K-93.5%	$1.1M	N/A	$62K-93.7%	$978K+531.0%	$155K	N/A	N/A	N/A	N/A

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Operating Cash Flow	-$3.3M-159.9%	-$1.0M-139.5%	$3.5M-17.9%	-$688K+86.5%	$5.5M+166.7%	$2.6M-44.7%	$4.2M-31.2%	-$5.1M-278.1%
Depreciation & Amortization	$1.6M-5.7%	$1.8M+93.6%	$1.2M+22.7%	$1.2M+29.8%	$1.7M+35.8%	$923K-21.0%	$944K+83.3%	$897K+71.5%
Stock-Based Compensation	$291K-31.2%	N/A	$354K-34.1%	$435K-22.9%	$423K+21.2%	N/A	$537K	$564K
Capital Expenditures	$644K+181.2%	$534K+227.6%	$407K-19.4%	$462K+46.2%	$229K-32.6%	$163K-47.1%	$505K+84.3%	$316K-15.7%
Free Cash Flow	-$4.0M-174.6%	-$1.6M-164.2%	$3.1M-17.7%	-$1.1M+78.7%	$5.3M+205.8%	$2.4M-44.6%	$3.7M-36.6%	-$5.4M-317.7%
Investing Cash Flow	-$644K-181.2%	-$534K-227.6%	-$407K+19.4%	-$462K-232.4%	-$229K+98.8%	-$163K+47.1%	-$505K-84.3%	-$139K+62.9%
Financing Cash Flow	$1.7M+148.9%	-$1.4M-187.6%	-$1.2M+80.4%	-$2.2M-125.0%	-$3.4M-289.7%	-$483K+50.2%	-$6.3M-313.6%	-$976K-105.1%
Share Buybacks	N/A	$0	N/A	N/A	N/A	$0	N/A	N/A

Not reported in any period shown, so not listed: Dividends Paid.

INTT Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

INTT quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	43.0%+0.6pp	42.4%-3.8pp	46.2%+0.5pp	45.7%-2.8pp	48.6%+3.8pp	44.8%-3.4pp	48.2%-2.0pp	50.1%-1.8pp	51.9%+1.3pp	50.7%+2.6pp	48.1%-0.9pp	49.0%+0.7pp	48.2%+4.3pp	43.9%-4.5pp	48.4%
Operating Margin	-3.3%-5.9pp	2.6%-5.9pp	8.5%-0.7pp	9.2%-0.8pp	10.0%+12.2pp	-2.3%-6.5pp	4.2%-2.4pp	6.6%+1.2pp	5.4%-4.9pp	10.3%+3.7pp	6.6%-5.2pp	11.8%+1.7pp	10.1%+3.1pp	6.9%-9.1pp	16.0%
Net Margin	-2.2%-4.4pp	2.2%-5.4pp	7.6%+0.3pp	7.2%-1.3pp	8.6%+10.2pp	-1.7%-5.5pp	3.8%0.0pp	3.9%+2.4pp	1.5%-5.2pp	6.6%+1.8pp	4.8%-3.4pp	8.2%+0.4pp	7.8%+2.8pp	5.0%-15.9pp	20.9%
Return on Equity	-2.4%-5.3pp	2.9%-6.8pp	9.7%-3.3pp	13.0%-0.3pp	13.3%+15.3pp	-2.0%-7.2pp	5.2%-1.9pp	7.1%+4.6pp	2.5%-4.5pp	7.0%+1.9pp	5.2%-4.8pp	10.0%+0.1pp	9.9%+2.1pp	7.8%-29.9pp	37.6%
Return on Assets	-1.7%-3.6pp	1.9%-5.0pp	6.9%-0.8pp	7.7%+0.7pp	7.0%+8.4pp	-1.4%-5.3pp	3.9%-0.6pp	4.5%+3.0pp	1.6%-4.6pp	6.2%+1.6pp	4.7%-4.2pp	8.9%+0.2pp	8.7%+2.0pp	6.7%-24.9pp	31.6%
Current Ratio	2.20-0.3x	2.47-1.1x	3.53+1.3x	2.23+0.2x	2.08-1.0x	3.04+0.1x	2.98+1.3x	1.66-0.5x	2.15-5.4x	7.52-0.9x	8.44+0.9x	7.54+0.8x	6.71+1.1x	5.59+0.7x	4.92
Debt-to-Equity	0.01-0.1x	0.080.0x	0.08-0.1x	0.19-0.1x	0.29+0.3x	0.00-0.3x	0.33-0.2x	0.570.0x	0.59+0.5x	0.130.0x	0.110.0x	0.130.0x	0.140.0x	0.160.0x	0.19
Asset Turnover	0.75-0.1x	0.86-0.1x	0.91-0.1x	1.06+0.2x	0.82-0.1x	0.87-0.1x	1.02-0.2x	1.17+0.1x	1.07+0.1x	0.940.0x	0.97-0.1x	1.080.0x	1.11-0.2x	1.34-0.2x	1.51
FCF Margin	5.0%+3.1pp	1.9%-10.2pp	12.1%+14.4pp	-2.4%-14.0pp	11.6%+6.8pp	4.8%+19.7pp	-14.9%-26.0pp	11.1%+1.4pp	9.7%-0.1pp	9.8%+2.4pp	7.4%-2.8pp	10.3%+1.8pp	8.5%-5.8pp	14.3%-0.6pp	14.9%

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Gross Margin	45.5%+4.0pp	45.4%+5.7pp	41.9%-4.4pp	42.6%+2.0pp	41.5%-2.3pp	39.7%-4.9pp	46.3%-0.4pp	40.6%-5.6pp
Operating Margin	2.8%+13.6pp	3.9%	-4.5%-6.2pp	-3.3%-4.3pp	-10.8%-12.5pp	N/A	1.6%-6.4pp	1.0%-9.3pp
Net Margin	2.3%+11.1pp	3.8%-0.3pp	-3.6%-5.2pp	-1.8%-2.5pp	-8.7%-11.0pp	4.1%-1.1pp	1.6%-5.7pp	0.7%-7.9pp
Return on Equity	0.8%+3.1pp	1.2%-0.3pp	-0.9%-1.4pp	-0.5%-0.7pp	-2.3%-3.0pp	1.5%0.0pp	0.5%-1.9pp	0.2%-2.8pp
Return on Assets	0.5%+2.1pp	0.8%-0.2pp	-0.6%-0.9pp	-0.3%-0.5pp	-1.6%-2.0pp	1.0%-0.1pp	0.3%-1.4pp	0.1%-2.0pp
Current Ratio	2.22-0.2x	2.20-0.3x	2.31+0.1x	2.42+0.2x	2.39+0.2x	2.47-1.1x	2.26-1.0x	2.24-1.0x
Debt-to-Equity	0.010.0x	0.01-0.1x	0.02-0.1x	0.04-0.1x	0.05-0.1x	0.080.0x	0.080.0x	0.090.0x
Asset Turnover	0.220.0x	0.220.0x	0.180.0x	0.190.0x	0.180.0x	0.240.0x	0.190.0x	0.210.0x
FCF Margin	-11.7%-31.6pp	-4.7%-11.4pp	11.8%-0.6pp	-4.1%+11.8pp	19.9%+14.1pp	6.6%-9.1pp	12.4%-6.7pp	-15.9%-23.5pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Intest INTT	FY2025	$113.8M	-$2.5M	-2.2%	$139.2M	51/100
Atomera Inc ATOM	FY2025	$65K	-$20.2M	N/A	$153.8M	—
Amtech Systems ASYS	FY2025	$79.4M	-$30.3M	-38.2%	$254.2M	52/100
Axt Inc AXTI	FY2025	$88.3M	-$21.3M	-24.1%	$3.7B	44/100
Trio Tech Int TRT	FY2025	$36.5M	-$41K	-0.1%	$99.7M	54/100
Veeco Instrs Inc Del VECO	FY2025	$664.3M	$35.4M	5.3%	$2.6B	57/100

Where Intest Ranks

Frequently Asked Questions

What is Intest's annual revenue?

Intest (INTT) reported $113.8M in total revenue for fiscal year 2025. This represents a -12.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Intest's revenue growing?

Intest (INTT) revenue declined by 12.9% year-over-year, from $130.7M to $113.8M in fiscal year 2025.

Is Intest profitable?

No, Intest (INTT) reported a net income of -$2.5M in fiscal year 2025, with a net profit margin of -2.2%.

What is Intest's EBITDA?

Intest (INTT) had EBITDA of $3.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Intest have?

As of fiscal year 2025, Intest (INTT) had $14.2M in cash and equivalents against $1.4M in long-term debt.

What is Intest's gross margin?

Intest (INTT) had a gross margin of 43.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Intest's operating margin?

Intest (INTT) had an operating margin of -3.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Intest's net profit margin?

Intest (INTT) had a net profit margin of -2.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Intest's return on equity (ROE)?

Intest (INTT) has a return on equity of -2.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Intest's free cash flow?

Intest (INTT) generated $5.7M in free cash flow during fiscal year 2025. This represents a 127.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Intest's operating cash flow?

Intest (INTT) generated $7.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Intest's total assets?

Intest (INTT) had $151.3M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Intest's capital expenditures?

Intest (INTT) invested $1.6M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Intest spend on research and development?

Intest (INTT) invested $9.4M in research and development during fiscal year 2025.

How many shares does Intest have outstanding?

Intest (INTT) had 12M shares outstanding as of fiscal year 2025.

What is Intest's current ratio?

Intest (INTT) had a current ratio of 2.20 as of fiscal year 2025, which is generally considered healthy.

What is Intest's debt-to-equity ratio?

Intest (INTT) had a debt-to-equity ratio of 0.01 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Intest's return on assets (ROA)?

Intest (INTT) had a return on assets of -1.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Intest's P/E ratio?

Intest (INTT) trades at 235x earnings, its market capitalization divided by net income of $591K net income, trailing 12 months to March 31, 2026. The market capitalization is $139.2M as of Sep 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Intest's price-to-sales ratio?

Intest (INTT) trades at 1.1x sales, its market capitalization divided by revenue of $121.1M revenue, trailing 12 months to March 31, 2026. The market capitalization is $139.2M as of Sep 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Intest's Altman Z-Score?

Intest (INTT) has an Altman Z-Score of 3.16, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Intest's Piotroski F-Score?

Intest (INTT) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Intest's earnings high quality?

Intest (INTT) reported a net loss of $2.5M while generating $7.3M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Intest cover its interest payments?

Intest (INTT) reported an operating loss of $3.7M against $450K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Intest?

Intest (INTT) scores 51 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.